Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
FOXO4-DRI (Proxofim) is manufactured by solid-phase peptide synthesis from synthetic origin, purified by preparative reversed-phase HPLC, and supplied as a white to off-white lyophilized powder at a purity of not less than 98% by HPLC
Hypoxia and high-altitude adaptation promote the expression of genes related to oxygen homeostasis and antioxidant defense by upregulating HIFs
These bonds are susceptible to hydrolysis (cleavage by water molecules) at non-neutral pH and elevated temperatures
While robust human clinical trials are still underway, preclinical studies and patient stories suggest several promising mechanisms: BPC-157 promotes angiogenesis, or the formation of new blood vessels
US$ 24.95
US$ 22.38
US$ 29.00
US$ 21.70
